Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

Background Dexamethasone decreases mortality in coronavirus disease 2019 (COVID-19)
patients on intensive respiratory support (IRS) but is of uncertain benefit if less severely ill …

Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …

Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …

In this study, we aimed to determine whether continuous renal replacement therapy (CRRT)
with oXiris filter may alleviate cytokine release syndrome (CRS) in non-AKI patients with …

As the COVID-19 pandemic is still ongoing, and considering the lack of efficacy of antiviral
strategies to this date, and the reactive hyperinflammation leading to tissue lesions and …

The effect of corticosteroid therapy is still controversial on prevention of mortality in
coronavirus disease‐2019 (COVID‐19). The objective of this study is to investigate the effect …

Background Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is
not clear. Methods In this systematic review and meta-analysis, we searched for studies on …